Inventor · disambiguated record
Arul M. Chinnaiyan
Also filed as: CHINNAIYAN ARUL · CHINNAIYAN ARUL M
52 granted patents·38 pending applications·311 citations·filing 2001–2024
98Inventor score
Top patents by PatentIndex Score
90 records- 0196US7718369B2Recurrent gene fusions in prostate cancerUNIV MICHIGAN·Filed 2006·Granted May 18, 2010·48 cites·5 claims
- 0294US10253044B29H-pyrimido [4,5-b]indoles and related analogs as BET bromodomain inhibitorsUNIV MICHIGAN REGENTS·Filed 2017·Granted Apr 9, 2019·11 cites·14 claims
- 0394US7229774B2Expression profile of prostate cancerUNIV MICHIGAN·Filed 2002·Granted Jun 12, 2007·89 cites·10 claims
- 0492US9745635B2Recurrent gene fusions in prostate cancerUNIV MICHIGAN REGENTS·Filed 2015·Granted Aug 29, 2017·4 cites·18 claims
- 0591US7597890B2Methods and compositions for diagnosing lung cancerUNIV MICHIGAN·Filed 2007·Granted Oct 6, 2009·16 cites·4 claims
- 0690US10190173B2Recurrent gene fusions in prostate cancerUNIV MICHIGAN REGENTS·Filed 2016·Granted Jan 29, 2019·3 cites·16 claims
- 0790US9580430B29H-pyrimido[4,5-B]indoles and related analogs as BET bromodomain inhibitorsUNIV MICHIGAN REGENTS·Filed 2015·Granted Feb 28, 2017·7 cites·18 claims
- 0890US8580509B2Recurrent gene fusions in prostate cancerTOMLINS SCOTT·Filed 2012·Granted Nov 12, 2013·7 cites·18 claims
- 0990US7858323B2Phage microarray profiling of the humoral response to diseaseUNIV MICHIGAN·Filed 2005·Granted Dec 28, 2010·12 cites·2 claims
- 1089US10407735B2Schlap-1 ncRNA and uses thereofUNIV MICHIGAN REGENTS·Filed 2016·Granted Sep 10, 2019·6 cites·15 claims
- 1189US9675697B2BET bromodomain inhibitors and therapeutic methods using the sameUNIV MICHIGAN REGENTS·Filed 2014·Granted Jun 13, 2017·16 cites·21 claims
- 1288US8211645B2Recurrent gene fusions in prostate cancerTOMLINS SCOTT·Filed 2009·Granted Jul 3, 2012·9 cites·17 claims
- 1385US10391175B2BET bromodomain inhibitors and therapeutic methods using the sameUNIV MICHIGAN REGENTS·Filed 2017·Granted Aug 27, 2019·6 cites·18 claims
- 1485US7332290B2Dectection of AMACR cancer markers in urineUNIV MICHIGAN·Filed 2004·Granted Feb 19, 2008·36 cites·8 claims
- 1584US9284609B2Recurrent gene fusions in prostate cancerTOMLINS SCOTT·Filed 2012·Granted Mar 15, 2016·3 cites·23 claims
- 1684US8617547B2Methods and compositions for diagnosing prostate cancerCHINNAIYAN ARUL·Filed 2009·Granted Dec 31, 2013·7 cites·22 claims
- 1782US9267133B2Phage microarray profiling of the humoral response to diseaseCHINNAIYAN ARUL·Filed 2010·Granted Feb 23, 2016·3 cites·26 claims
- 1881US11390923B2ncRNA and uses thereofUNIV MICHIGAN REGENTS·Filed 2019·Granted Jul 19, 2022·1 cites·7 claims
- 1980US7968294B2SLIT2 underexpression in metastatic prostate cancerUNIV MICHIGAN·Filed 2009·Granted Jun 28, 2011·2 cites·7 claims
- 2080US7700293B2Expression profile of prostate cancerUNIV MICHIGAN·Filed 2007·Granted Apr 20, 2010·6 cites·9 claims
- 2178US11746151B2Compositions and methods for treating cancerUNIV MICHIGAN REGENTS·Filed 2019·Granted Sep 5, 2023·2 cites·9 claims
- 2276US8969527B2Recurrent gene fusions in prostate cancerTOMLINS SCOTT·Filed 2012·Granted Mar 3, 2015·1 cites·11 claims
- 2376US7767393B2Expression profile of prostate cancerUNIV MICHIGAN·Filed 2006·Granted Aug 3, 2010·4 cites·4 claims
- 2475US9783853B2Recurrent gene fusions in cancerUNIV MICHIGAN REGENTS·Filed 2014·Granted Oct 10, 2017·2 cites·6 claims
- 2575US2023016456A1ncRNA AND USES THEREOFUNIV MICHIGAN REGENTS·Filed 2022·Application pending·0 cites
- 2674US9957569B2Recurrent gene fusions in prostate cancerCHINNAIYAN ARUL M·Filed 2008·Granted May 1, 2018·2 cites·23 claims
- 2774US8524682B2Compositions and methods for inhibiting EZH2CHINNAIYAN ARUL M·Filed 2010·Granted Sep 3, 2013·4 cites·4 claims
- 2873US11013754B2Compositions and methods for treating cancerUNIV MICHIGAN REGENTS·Filed 2019·Granted May 25, 2021·1 cites·9 claims
- 2972US9938582B2Recurrent gene fusions in prostate cancerCHINNAIYAN ARUL M·Filed 2010·Granted Apr 10, 2018·2 cites·6 claims
- 3070US12270080B2NcRNA and uses thereofUNIV MICHIGAN REGENTS·Filed 2019·Granted Apr 8, 2025·0 cites·7 claims
- 3170US10174381B2Systems and methods for determining a treatment course of actionUNIV MICHIGAN REGENTS·Filed 2014·Granted Jan 8, 2019·1 cites·6 claims
- 3269US2018265861A1Phage microarray profiling of the humoral response to diseaseUNIV MICHIGAN REGENTS·Filed 2018·Application pending·0 cites
- 3368US9303291B2MIPOL1-ETV1 gene rearrangementsCHINNAIYAN ARUL M·Filed 2008·Granted Apr 5, 2016·0 cites·11 claims
- 3467US2025034648A1Kits and methods useful for prognosing, diagnosing, and treating prostate cancerUNIV MICHIGAN REGENTS·Filed 2024·Application pending·0 cites
- 3566US11697852B2Systems and methods for determining a treatment course of actionUNIV MICHIGAN REGENTS·Filed 2019·Granted Jul 11, 2023·0 cites·7 claims
- 3666US10006023B2Phage microarray profiling of the humoral response to diseaseUNIV MICHIGAN REGENTS·Filed 2016·Granted Jun 26, 2018·0 cites·34 claims
- 3766US8058003B2ADRB2 cancer markersCHINNAIYAN ARUL M·Filed 2008·Granted Nov 15, 2011·0 cites·6 claims
- 3866US2025144107A1Use of a pikfyve inhibitor in combination with immunotherapyUNIV MICHIGAN REGENTS·Filed 2024·Application pending·0 cites
- 3965US2025100994A1Cdk12/13 covalent inhibitors or pharmaceutical composition thereof, and uses thereofUNIV MICHIGAN REGENTS·Filed 2024·Application pending·0 cites
- 4063US2009012031A1EZH2 Cancer MarkersUNIV MICHIGAN·Filed 2008·Application pending·0 cites
- 4162US10167517B2MIPOL1-ETV1 gene rearrangementsUNIV MICHIGAN REGENTS·Filed 2017·Granted Jan 1, 2019·0 cites·22 claims
- 4261US11307203B2Using phage epitopes to profile the immune responseUNIV MICHIGAN REGENTS·Filed 2018·Granted Apr 19, 2022·0 cites·7 claims
- 4361US9719143B2MIPOL1-ETV1 gene rearrangementsUNIV MICHIGAN REGENTS·Filed 2016·Granted Aug 1, 2017·0 cites·16 claims
- 4460US11015224B2RAF gene fusionsUNIV MICHIGAN REGENTS·Filed 2016·Granted May 25, 2021·0 cites·14 claims
- 4560US10815484B2Compositions and methods for treating cancerUNIV MICHIGAN REGENTS·Filed 2018·Granted Oct 27, 2020·0 cites·11 claims
- 4659US10041123B2Recurrent gene fusions in prostate cancerCHINNAIYAN ARUL M·Filed 2007·Granted Aug 7, 2018·0 cites·23 claims
- 4759US8900819B2ADRB2 cancer markersCHINNAIYAN ARUL M·Filed 2011·Granted Dec 2, 2014·0 cites·2 claims
- 4859US2016251729A1ncRNA AND USES THEREOFUNIV MICHIGAN REGENTS·Filed 2016·Application pending·0 cites
- 4959US2023364084A1Methods for preventing or treating conditions related to pikfyve activityUNIV MICHIGAN REGENTS·Filed 2021·Application pending·0 cites
- 5058US2015284802A1ncRNA AND USES THEREOFCHINNAIYAN ARUL·Filed 2011·Application pending·0 cites
Showing the top 50 of 90 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →